رسائل ماجيستير
French
2010
Immunomodulation In Vivo Et In Vitro De La Balance Inflammatoire Des Macrophages Induits Par La Venin D'androctonus Australis Hector Et Sa Toxine Aah II, En Présence Et En Absence D'immunothérapie
F. Laraba-Djebari, لامية علواش
كلية العلوم البيولوجية-جامعة العلوم والتكنولوجيا هواري بومدين - الجزائر · الجزائر
In this work, we noted in vivo and in vitro effect activator, cytotoxic and immunomodulating scorpion venom of Androctonus Australis hector and its toxin Aah II on peritoneal macrophages of mice BALB 1 c, and this was in the presence and/or absence of immunotherapy. The stimulation of macrophages in vitro by a low dose of venom A ah or toxin Aah II at different incubation times showed the increased production and extended by sorne inflammatory mediators such as H202 (hydrogen peroxide) and NO (nitric oxide) and sorne cytokines such as IL-6, TNF-a, IL-l~, IFNy, IL-12, and IL-l O. Balance of inflammatory cytokines is involved between 24 h and 72 h. In parallel, the in vitro calculated percentage of cytotoxicity of macrophages was highest at 24 hours. However, the in vitro pre-treatment of macrophages with dexamethasone at a concentration of 1 o-7 M, 24 h before the addition of venom or toxin Aah II, has remarkably decreased the amount of hydrogen peroxide as well as the cytotoxicity of the macrophages. In vivo or in vitro stimulation macrophage by the venom or its toxin Aah II also increased the amount of MDA (malonaldehyde) marker of lipid peroxidation. On the other hand, the influence of Aah venom or its toxin Aah II on antioxidant system of the macrophage was assessed by measuring GSH (reduced glutathione) intra cellular. A substantial and prolonged reduction in levels of GSH was observed after 30 min of treatment in vitro by the venom and between 30 min and after 24 h of administration in vivo by toxin Aah II. In fact, ali the parameters previously calculated (cytotoxicity, H202, NO, MDA, and GSH) were more or less reduced after immunotherapy. These results suggest that the venom and its toxin Aah II to lower doses can disturb the balance of inflammatory macrophages by creating an oxidative stress in their microenvironment, which may be toxic to these cells, and is apparently poorly controlled by anti-oxidant and anti-inflammatory cytokines, but may be partially offset during immunotherapy.